Exact Sciences aims to build on the success of Cologuard® through the development of Cologuard 2.0, a stool DNA test with enhanced performance characteristics without losing the simplicity and convenience of an at-home test. The goals with Cologuard 2.0 are to increase test performance and further improve the patient experience to reinforce Cologuard as the best-in-class non-invasive screening option. Samples collected from the BLUE-C clinical trial will be used to establish the performance characteristics of Cologuard 2.0 and support a submission for FDA approval.
